ELVElevance Health Inc.
Elevance Health Inc. (ELV) is a health care services company that provides managed care services, pharmacy benefits management, and health insurance products. The company’s next catalyst is Oct 20, 2026 — Q3 2026 Earnings Release, which will test its ability to deliver strong financial results amid ongoing regulatory and market pressures.
- Revenue reached $201.14B in 2026, with a 12.5% YoY growth.
- Free cash flow (TTM) stands at $15.81B, reflecting strong operational efficiency.
- Net margin (TTM) is 3.1%, with a debt-to-equity ratio of 0.73x.
The schedule
- Tue20Oct
ELV reports Q3 results with focus on MLR and Medicare Advantage membership following Q2's weakness.
- Thu12Nov
The evolving legislative landscape post-midterms under President Trump poses risks to ACA subsidies and PBM margins.
- Tue9Feb
ELV issues Q4 2026 financials and initial FY2027 EPS and MLR guidance.
- Wed17Feb
CMS issues proposed benchmark payment rates for 2028 MA plans.
- Mon5Apr
CMS publishes finalized 2028 payment rates, cementing revenue assumptions for ELV's MA segment.
- Wed21Apr
ELV details Q1 2027 operating performance, revealing early outcomes of FY2027 cost-containment initiatives.
- Wed21Jul
ELV reports mid-year 2027 commercial utilization and MLR trends.
Past
- Wed15Jul
Actual outcome: Bear · $377.68 at outcome
Elevance Health reported a Q2 earnings beat and raised its full-year 2026 adjusted EPS outlook, citing favorable benefit expense performance. Despite the positive headline results, the stock declined to the bear floor as investors focused on underlying weaknesses, including softer membership, lower year-over-year earnings, and broader industry headwinds such as hospital systems dropping Medicare Advantage plans.
Elevance Health reported a Q2 earnings beat and raised its full-year 2026 adjusted EPS outlook, citing favorable benefit expense performance. Despite the positive headline results, the stock declined to the bear floor as investors focused on underlying weaknesses, including softer membership, lower year-over-year earnings, and broader industry headwinds such as hospital systems dropping Medicare Advantage plans.